Nkarta, Inc. Banner Image

Nkarta, Inc.

  • Ticker NKTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Nkarta, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activityMore and intended for broad access in the outpatient treatment setting.
5.0 / 5.0 (1)

Nkarta, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Nkarta, Inc.

Most Recent Annual Report

Nkarta, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Nkarta, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!